Diabetes Mellitus Clinical Trial
Official title:
Analysis of Viral Infections' Exposition Preceding the Type 1 Diabetes (T1D) Diagnostic in Children of the Isis-Diab Cohort. Search for Explanations of of the Disease's Early Onset
The purpose of this study is to investigate viral factors determining the early onset of T1D. Thanks to the quantification of viral exposures of T1D patients before the disease onset with questionnaires and environmental databases analyses, and through whole genome association studies of these patients, investigators could attempt to identify gene-virus interactions determining the age of T1D onset.
The "hygiene hypothesis", which has been proposed to explain the observed increase of the
incidence of T1D, relies on experimental evidence acquired in mouse models. However,
epidemiological data are still lacking to validate this hypothesis in man. This is critical,
because -in opposition with the hygiene hypothesis- there are many reasons to believe that,
at contrary, certain virus can trigger the disease.
Genetic predisposition to a severe infection form (particularly primary infection) was
demonstrated for several infectious diseases (Casanova JL, Science 317:617-619, 2007;
Casanova JL, EMBO J 26:915-922, 2007). It usually corresponds to deficiencies in genes
involved in the host's immune response, the transmission of which being Mendelian. Genetic
factors affect the ability of enteroviruses and other viruses to damage beta cells and to
induce diabetes. Recently, Nejentsev et al have demonstrated a link between enteroviruses
and diabetes genes: they have indeed identified 4 rare IFIH1 polymorphisms that reduce the
T1D risk. However, this gene encodes an enzyme recognizing the DNA enterovirus, causing
immunity activation; mutations inhibit gene activation. Except one study on HIV-1, there is
to our knowledge no genome wide association studies (GWAS) in humans on the role of host's
genetic polymorphisms in the risk of infection, clinical expression, duration of viral
shedding, or response to therapy or to anti-viral vaccines.
We relied on our cohort of T1D children (Isis-Diab) to investigate the possible relation
between viral exposures, genetic polymorphisms, and subsequent T1D.
The search for viral factors responsible for the increased T1D prevalence in youth children
is difficult to implement. The absence or scarcity of infections is difficult to assess
robustly at the individual level. The analysis of digestive, ENT or blood samples in the
search for viruses themselves can only be done at T1D diagnosis and is therefore unlikely to
be positive several years after the causal infection. It is not possible to reconstitute
retrospectively viral events, which an individual has been exposed between birth and date of
diabetes diagnosis. That is why our project proposes to use a proxy of viral infections
crossed by a child, quantifying viral exposures to which he was submitted before the T1D
diagnosis. We focused on early childhood's viral infections that may interfere with early
forms of T1D. We combine 2 data sources:
- The geolocation of the child's address will locate places where he lives.
Spatio-temporal data from Sentinel Network, collected since 1984, will provide access
on the following viral exposures: seasonal influenza, viral diarrhea (mostly
enteroviral), mumps, measles, chickenpox. If the defect of our approach is that it does
not see real viral infections experienced by children, but only the level of exposure
to which they were exposed according to their address, the advantage is an objective
spatio-temporal description of virus epidemics around children, making it more or less
likely infection of these. Only France has such Sentinel data.
- Vaccination (including MMR) and information on infectious past of children will be
collected from data recorded in his book health. We will focus on the mother's
pregnancy and the child between birth and 2 years of age.
Environmental data from these 2 sources will be crossed with already available genetic data
from GWAS to identify gene-virus associations potentially determining age of T1D onset. This
"high dimensionality" analysis will be addressed with "machine learning" programs.
If avoidable risks are identified, it would be possible to think to design clinical trials
for prevention of the identified forms of T1D.
;
Observational Model: Case-Only, Time Perspective: Retrospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03743779 -
Mastering Diabetes Pilot Study
|
||
Completed |
NCT03786978 -
Pharmaceutical Care in the Reduction of Readmission Rates in Diabetes Melitus
|
N/A | |
Completed |
NCT01804803 -
DIgital Assisted MONitoring for DiabeteS - I
|
N/A | |
Completed |
NCT05039970 -
A Real-World Study of a Mobile Device-based Serious Health Game on Session Attendance in the National Diabetes Prevention Program
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Completed |
NCT04068272 -
Safety of Bosentan in Type II Diabetic Patients
|
Phase 1 | |
Completed |
NCT03243383 -
Readmission Prevention Pilot Trial in Diabetes Patients
|
N/A | |
Completed |
NCT03730480 -
User Performance of the CONTOUR NEXT and CONTOUR TV3 Blood Glucose Monitoring System (BGMS)
|
N/A | |
Recruiting |
NCT02690467 -
Efficacy, Safety and Acceptability of the New Pen Needle 34gx3,5mm.
|
N/A | |
Completed |
NCT02229383 -
Phase III Study to Evaluate Safety and Efficacy of Added Exenatide Versus Placebo to Titrated Basal Insulin Glargine in Inadequately Controlled Patients With Type II Diabetes Mellitus
|
Phase 3 | |
Completed |
NCT06181721 -
Evaluating Glucose Control Using a Next Generation Automated Insulin Delivery Algorithm in Patients With Type 1 and Type 2 Diabetes
|
N/A | |
Completed |
NCT05799976 -
Text Message-Based Nudges Prior to Primary Care Visits to Increase Care Gap Closure
|
N/A | |
Recruiting |
NCT04489043 -
Exercise, Prediabetes and Diabetes After Renal Transplantation.
|
N/A | |
Withdrawn |
NCT03319784 -
Analysis for NSAID VS Corticosteroid Shoulder Injection in Diabetic Patients
|
Phase 4 | |
Completed |
NCT03542084 -
Endocrinology Auto-Triggered e-Consults
|
N/A | |
Completed |
NCT02229396 -
Phase 3 28-Week Study With 24-Week and 52-week Extension Phases to Evaluate Efficacy and Safety of Exenatide Once Weekly and Dapagliflozin Versus Exenatide and Dapagliflozin Matching Placebo
|
Phase 3 | |
Recruiting |
NCT05544266 -
Rare and Atypical Diabetes Network
|
||
Completed |
NCT01892319 -
An International Non-interventional Cohort Study to Evaluate the Safety of Treatment With Insulin Detemir in Pregnant Women With Diabetes Mellitus. Diabetes Pregnancy Registry
|
||
Completed |
NCT05031000 -
Blood Glucose Monitoring Systems: Discounter Versus Brand
|
N/A | |
Recruiting |
NCT04039763 -
RT-CGM in Young Adults at Risk of DKA
|
N/A |